Skip to main content

Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread.

Publication ,  Journal Article
Batich, KA; Riedel, RF; Kirkpatrick, JP; Tong, BC; Eward, WC; Tan, CL; Pittman, PD; McLendon, RE; Peters, KB
Published in: Front Oncol
2019

Myxopapillary ependymomas are a slow-growing, grade I type glial tumor in the lumbosacral region. More rarely, they can present as extradural, subcutaneous sacrococcygeal, or perisacral masses, and it is under these circumstances that they are more likely to spread. Here, we report the presentation of a sacrococcygeal mass in patient that was initially resected confirming extradural myxopapillary ependymoma. At initial resection, multiple small pulmonary nodules were detected. This mass recurred 2 years later at the resection site with an interval increase in the previously imaged pulmonary nodules. Resection of both the post-sacral mass and largest lung metastasis confirmed recurrent myxopapillary ependymoma with oligometastatic spread. Because these tumors are rare, with extradural presentation being even more infrequent, to this date there are no definitive therapeutic guidelines for initial treatment and continued surveillance. For myxopapillary ependymoma, current standard of care is first-line maximal surgical resection with or without postoperative radiotherapy depending on the extent of disease and extent of resection. However, there remains insufficient evidence on the role of radiotherapy to oligometastatic foci in providing any further survival benefit or extending time to recurrence. Thus, prospective studies assessing the role of upfront treatment of oligometastases with local resection and adjuvant radiotherapy are needed for improved understanding of extradural myxopapillary ependymoma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Front Oncol

DOI

ISSN

2234-943X

Publication Date

2019

Volume

9

Start / End Page

1322

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Batich, K. A., Riedel, R. F., Kirkpatrick, J. P., Tong, B. C., Eward, W. C., Tan, C. L., … Peters, K. B. (2019). Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread. Front Oncol, 9, 1322. https://doi.org/10.3389/fonc.2019.01322
Batich, Kristen A., Richard F. Riedel, John P. Kirkpatrick, Betty C. Tong, William C. Eward, Char Loo Tan, Patricia D. Pittman, Roger E. McLendon, and Katherine B. Peters. “Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread.Front Oncol 9 (2019): 1322. https://doi.org/10.3389/fonc.2019.01322.
Batich KA, Riedel RF, Kirkpatrick JP, Tong BC, Eward WC, Tan CL, et al. Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread. Front Oncol. 2019;9:1322.
Batich, Kristen A., et al. “Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread.Front Oncol, vol. 9, 2019, p. 1322. Pubmed, doi:10.3389/fonc.2019.01322.
Batich KA, Riedel RF, Kirkpatrick JP, Tong BC, Eward WC, Tan CL, Pittman PD, McLendon RE, Peters KB. Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread. Front Oncol. 2019;9:1322.

Published In

Front Oncol

DOI

ISSN

2234-943X

Publication Date

2019

Volume

9

Start / End Page

1322

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis